Who owns PTC THERAPEUTICS, INC. (PTCT)? Elite investor 13F holders
4 tracked elite investors reported holding PTC THERAPEUTICS, INC as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, Tudor Investment, Polen Capital Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company provides Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | PTC THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 126345323.00 USD | 1548919.000000 | Shares | reduce | Original filing |
| Renaissance Technologies LLC | PTC THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 59015895.00 USD | 723500.000000 | Shares | add | Original filing |
| Tudor Investment | PTC THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1120690.00 USD | 13739.000000 | Shares | reduce | Original filing |
| Polen Capital Management | PTC THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 2032398.00 USD | 24916.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.